Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients
I. Zahoor, J. Waters, N. Ata, I. Datta, T. Pedersen, M. Cerghet, L. Poisson, S. Markovic-Plese, R. Rattan, A. Y. Taha, J. W. Newman, S. Giri
The paper identifies altered omega fatty acid-derived lipid mediators in RRMS patients using metabolipidomics, suggesting their potential as biomarkers for diagnosis and prognosis.
bioRxiv · Jan 4, 2024 · PreprintBiochemistry